
Michael P. Cohen
Examiner (ID: 1646)
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 987 |
| Issued Applications | 527 |
| Pending Applications | 118 |
| Abandoned Applications | 371 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20517718
[patent_doc_number] => 20260041821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-12
[patent_title] => DRUG-RELEASING COATING
[patent_app_type] => utility
[patent_app_number] => 19/350447
[patent_app_country] => US
[patent_app_date] => 2025-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19350447
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/350447 | DRUG-RELEASING COATING | Oct 5, 2025 | Pending |
Array
(
[id] => 20458229
[patent_doc_number] => 20260007649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS
[patent_app_type] => utility
[patent_app_number] => 19/326649
[patent_app_country] => US
[patent_app_date] => 2025-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19326649
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/326649 | METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS | Sep 10, 2025 | Pending |
Array
(
[id] => 20254851
[patent_doc_number] => 12427184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Treatment of immunosuppressed subjects
[patent_app_type] => utility
[patent_app_number] => 19/186092
[patent_app_country] => US
[patent_app_date] => 2025-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 16899
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19186092
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/186092 | Treatment of immunosuppressed subjects | Apr 21, 2025 | Issued |
Array
(
[id] => 20083555
[patent_doc_number] => 20250213491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => POLYMER-ENCAPSULATED DRUG PARTICLES
[patent_app_type] => utility
[patent_app_number] => 19/081631
[patent_app_country] => US
[patent_app_date] => 2025-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19081631
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/081631 | POLYMER-ENCAPSULATED DRUG PARTICLES | Mar 16, 2025 | Pending |
Array
(
[id] => 19830796
[patent_doc_number] => 20250082582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => POLYMER-ENCAPSULATED DRUG PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/955058
[patent_app_country] => US
[patent_app_date] => 2024-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18955058
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/955058 | POLYMER-ENCAPSULATED DRUG PARTICLES | Nov 20, 2024 | Pending |
Array
(
[id] => 19629683
[patent_doc_number] => 20240408132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => HYPOHALOUS ACIDS FOR TREATING INFLAMMATORY DISEASES AND INHIBITING GROWTH OF MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 18/811505
[patent_app_country] => US
[patent_app_date] => 2024-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18811505
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/811505 | HYPOHALOUS ACIDS FOR TREATING INFLAMMATORY DISEASES AND INHIBITING GROWTH OF MALIGNANCIES | Aug 20, 2024 | Pending |
Array
(
[id] => 19930359
[patent_doc_number] => 12303552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Treatment of immunosuppressed subjects
[patent_app_type] => utility
[patent_app_number] => 18/808392
[patent_app_country] => US
[patent_app_date] => 2024-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 16931
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18808392
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/808392 | Treatment of immunosuppressed subjects | Aug 18, 2024 | Issued |
Array
(
[id] => 19882982
[patent_doc_number] => 12268664
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-04-08
[patent_title] => Administration of benzodiazepine compositions
[patent_app_type] => utility
[patent_app_number] => 18/782666
[patent_app_country] => US
[patent_app_date] => 2024-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25392
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18782666
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/782666 | Administration of benzodiazepine compositions | Jul 23, 2024 | Issued |
Array
(
[id] => 19792234
[patent_doc_number] => 12233157
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-02-25
[patent_title] => Hydrogel formulations and methods and devices for administration of the same
[patent_app_type] => utility
[patent_app_number] => 18/783305
[patent_app_country] => US
[patent_app_date] => 2024-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 22346
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783305
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/783305 | Hydrogel formulations and methods and devices for administration of the same | Jul 23, 2024 | Issued |
Array
(
[id] => 19553988
[patent_doc_number] => 20240365780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => MICROBIAL INOCULANT COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/777004
[patent_app_country] => US
[patent_app_date] => 2024-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777004
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/777004 | MICROBIAL INOCULANT COMPOSITIONS AND METHODS | Jul 17, 2024 | Pending |
Array
(
[id] => 19722663
[patent_doc_number] => 20250025414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => READY-DELIVERY ORAL DOSAGE FORM FOR LABORATORY ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/774109
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774109
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774109 | READY-DELIVERY ORAL DOSAGE FORM FOR LABORATORY ANIMALS | Jul 15, 2024 | Pending |
Array
(
[id] => 19707752
[patent_doc_number] => 20250017894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => Formulation for Nasal Delivery of Cannabinoids
[patent_app_type] => utility
[patent_app_number] => 18/745406
[patent_app_country] => US
[patent_app_date] => 2024-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745406
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/745406 | Formulation for Nasal Delivery of Cannabinoids | Jun 16, 2024 | Pending |
Array
(
[id] => 20418604
[patent_doc_number] => 20250380689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-18
[patent_title] => METHOD FOR MITIGATING MICROBIAL ACTIVITY USING ANTIMICROBIAL ARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/743204
[patent_app_country] => US
[patent_app_date] => 2024-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18743204
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/743204 | METHOD FOR MITIGATING MICROBIAL ACTIVITY USING ANTIMICROBIAL ARTICLES | Jun 13, 2024 | Pending |
Array
(
[id] => 19984111
[patent_doc_number] => 20250122333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/674209
[patent_app_country] => US
[patent_app_date] => 2024-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18674209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/674209 | POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF | May 23, 2024 | Pending |
Array
(
[id] => 19462307
[patent_doc_number] => 20240315976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => POLYMER-ENCAPSULATED DRUG PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/672320
[patent_app_country] => US
[patent_app_date] => 2024-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18672320
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/672320 | POLYMER-ENCAPSULATED DRUG PARTICLES | May 22, 2024 | Pending |
Array
(
[id] => 19462314
[patent_doc_number] => 20240315983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => DRUG DELIVERY SYSTEMS CONTAINING OXIDIZED CHOLESTEROLS
[patent_app_type] => utility
[patent_app_number] => 18/672534
[patent_app_country] => US
[patent_app_date] => 2024-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18672534
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/672534 | DRUG DELIVERY SYSTEMS CONTAINING OXIDIZED CHOLESTEROLS | May 22, 2024 | Pending |
Array
(
[id] => 19585090
[patent_doc_number] => 20240382647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => Method for Preparing an Intramammary Teat Sealing Composition and Sealing Composition Obtained By Such Process
[patent_app_type] => utility
[patent_app_number] => 18/667477
[patent_app_country] => US
[patent_app_date] => 2024-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18667477
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/667477 | Method for Preparing an Intramammary Teat Sealing Composition and Sealing Composition Obtained By Such Process | May 16, 2024 | Pending |
Array
(
[id] => 19554851
[patent_doc_number] => 20240366643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/662516
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662516
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662516 | Methods for treating pulmonary non-tuberculous mycobacterial infections | May 12, 2024 | Issued |
| 18/707002 | DICLOFENAC-CONTAINING TTS COMPRISING DIMETHYLPROPYLENEUREA | May 1, 2024 | Pending |
Array
(
[id] => 19432502
[patent_doc_number] => 20240301000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => TETRAPEPTIDE DERIVATIVE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/653953
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653953
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/653953 | TETRAPEPTIDE DERIVATIVE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF | May 1, 2024 | Pending |